Ascorbyl dipalmitate/PEG-lipid nanoparticles as a novel carrier for hydrophobic drugs

International Journal of Pharmaceutics

Volumn 387, Issue 1-2, 2010, Pages 236-243

  Moribe, Kunikazu ^a   Maruyama, Sunao ^a   Inoue, Yutaka ^b   Suzuki, Toyofumi ^c   Fukami, Toshiro ^c   Tomono, Kazuo ^c   Higashi, Kenjirou ^a   Tozuka, Yuichi ^d   Yamamoto, Keiji ^a  

^a CHIBA UNIVERSITY   (Japan)

^b JOSAI UNIVERSITY   (Japan)

^c NIHON UNIVERSITY   (Japan)

^d GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Amphotericin B; Ascorbyl dipalmitate; Complex; DSPE PEG; Nanoparticle

Indexed keywords

ACETOHEXAMIDE; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ASCORBIC ACID DERIVATIVE; ASCORBYL 2,6 DIPALMITATE; ASCORBYL PALMITATE; CALCEIN; CLARITHROMYCIN; COLECALCIFEROL; DEOXYCHOLATE SODIUM; FLUCONAZOLE; LIPOSOME; MACROGOL; MACROGOL 2000; NANOPARTICLE; NYSTATIN; SURFACTANT; THIOCTIC ACID; UBIDECARENONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HYDROPHOBICITY; LD 50; LIVER TOXICITY; MEAN RESIDENCE TIME; MICELLE; MOUSE; NEPHROTOXICITY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SOLVATION; TOXICITY TESTING; ZETA POTENTIAL;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; ASCORBIC ACID; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG STABILITY; HYDROPHOBICITY; MALE; MICE; NANOPARTICLES; PALMITATES; PARTICLE SIZE; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; SOLUBILITY; SURFACE-ACTIVE AGENTS; TOXICITY TESTS;

EID: 77649186629     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.12.007     Document Type: Article

References (19)

1. Bilia A.R., Bergonzi M.C., Vincieri F.F., Nostro P.L., Morris G.A. A diffusion-ordered NMR spectroscopy study of the solubilization of artemisinin by octanoyl-6-O-ascorbic acid micelles. J. Pharm. Sci. 2002, 91:2265-2270.
2. Fočo A., Gašperlin M., Kristl J. Investigation of liposomes as carriers of sodium ascorbyl phosphate for cutaneous photoprotection. Int. J. Pharm. 2005, 291:21-29.
3. Gopinath D., Ravi D., Rao B.R., Apte S.S., Renuka D., Rambhau D. Ascorbyl palmitate vesicles (Aspasomes): formation, characterization and applications. Int. J. Pharm. 2004, 271:95-113.
4. Inoue Y., Yoshimura S., Tozuka Y., Moribe K., Kumamoto T., Ishikawa T., Yamamoto K. Application of ascorbic acid 2-glucoside as a solubilizing agent for clarithromycin: solubilization and nanoparticle formation. Int. J. Pharm. 2007, 331:38-45.
5. Lien M.H., Huang B.C., Hsu M.C. Determination of ascorbyl dipalmitate in cosmetic whitening powders by liquid chromatography. J. Chromatogr. 1993, 645:362-365.
6. Llabot J.M., Palma S.D., Manzo R.H., Allemandi D.A. Design of novel antifungal mucoadhesive films. Part I: Pre-formulation studies. Int. J. Pharm. 2007, 330:54-60.
7. LoNostro P., Capuzzi G., Pinelli P., Mulinacci N., Romani A., Vincieri F.F. Self-assembling and antioxidant activity of some vitamin C derivatives. Colloid. Surf. Physicochem. Eng. Aspect. 2000, 167:83-93.
8. Matsukawa H., Yagi T., Matsuda H., Kawahara H., Yamamoto I., Matsuoka J., Tanaka N. Ascorbic acid 2-glucoside prevents sinusoidal endothelial cell apoptosis in supercooled preserved grafts in rat liver transplantation. Transplant. Proc. 2000, 32:313-317.
9. Moribe K., Tanaka E., Maruyama K., Iwatsuru M. Enhanced encapsulation of amphotericin B into liposomes by complex formation with polyethylene glycol derivatives. Pharm. Res. 1998, 15:1737-1742.
10. Nishiyama N., Kataoka K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol. Ther. 2006, 112:630-648.
11. Ratnam D.V., Ankola D.D., Bhardwaj V., Sahana D.K., Ravi Kumar M.N.V. Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. J. Control. Release 2006, 113:189-207.
12. Sawant R.M., Hurley J.P., Salmaso S., Kale A., Tolcheva E., Levchenko T.S., Torchilin V.P. "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjug. Chem. 2006, 17:943-949.
13. Špiclin P., Gašperlin M., Kmetec V. Stability of ascorbyl palmitate in topical microemulsions. Int. J. Pharm. 2001, 222:271-279.
14. Takebayashi J., Tai A., Gohda E., Yamamoto I. Characterization of the radical-scavenging reaction of 2-O-substituted ascorbic acid derivatives, AA-2G, AA-2P, and AA-2S: a kinetic and stoichiometric study. Biol. Pharm. Bull. 2006, 29:766-771.
15. Tanaka H., Yamamoto R. Pharmaceutical studies on ascorbic acid derivatives. Yakugakuzasshi 1996, 86:376-383.
16. Teeranachaideekul V., Junyaprasert V.B., Souto E.B., Müller R.H. Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology. Int. J. Pharm. 2008, 354:227-234.
17. Yamada Y., Harashima H. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases. Adv. Drug Deliv. Rev. 2008, 60:439-462.
18. Yamamoto H., Kuno Y., Sugimoto S., Takeuchi H., Kawashima Y. Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J. Control. Release 2005, 102:373-381.
19. Yamamoto I., Muto N., Nagata E., Nakamura T., Suzuki Y. Formation of a stable l-ascorbic acid α-glucoside by mammalian α-glucosidase-catalyzed transglucosylation. Biochim. Biophys. Acta 1990, 1035:44-50.